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Abstract
Insertion of an aspartate residue at position 345a in penicillin-binding protein 2 (PBP 2), which
lowers the rate of penicillin acylation by ~6-fold, is commonly observed in penicillin-resistant
strains of Neisseria gonorrhoeae. Here, we show that insertions of other amino acids also lower the
penicillin acylation rate of PBP 2, but none supported growth of N. gonorrhoeae, indicating loss of
essential transpeptidase activity. The Asp345a mutation likely acts by altering the interaction
between its adjacent residue, Asp346, in the β2a-β2d hairpin loop and Ser363, the middle residue
of the SXN active site motif. Because the adjacent aspartate creates ambiguity in the position of
the insertion, we also examined if insertions at position 346a could confer decreased susceptibility
to penicillin. However, only aspartate insertions were identified, indicating that only an Asp-Asp
couple can confer resistance and retain transpeptidase function. The importance of the Asp346-
Ser363 interaction was assessed by mutation of each residue to Ala. Although both mutants
lowered the acylation rate of penicillin G by 5-fold, neither could support growth of N.
gonorrhoeae, again indicating loss of transpeptidase function. Interaction between a residue in the
equivalent of the β2a-β2d hairpin loop and the middle residue of the SXN motif is observed in
crystal structures of other Class B PBPs and its importance is also supported by multi-sequence
alignments. Overall, these results suggest that this conserved interaction can be manipulated (e.g.
by insertion) to lower the acylation rate by β-lactam antibiotics and increase resistance, but only if
essential transpeptidase activity is preserved.
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Introduction
Neisseria gonorrhoeae is an obligate human pathogen that is the etiologic agent of the
sexually transmitted infection gonorrhea. In 2007, over 350,000 infections were reported in
the U.S. (1), but the actual number may be twice that. Gonococcal infections in females are
often asymptomatic and, if left untreated, can progress to pelvic inflammatory disease. There
is a risk of disseminated infections in both sexes, and individuals infected with N.
gonorrhoeae have an increased likelihood of both transmitting and acquiring HIV (2, 3).
Because of the lack of a robust immune response or an effective vaccine, antibiotics are the
mainstay for treating gonococcal infections.
Historically, N. gonorrhoeae has become resistant to nearly all antibiotics that have been
used to treat infections, including penicillin, tetracycline, azithromycin, and
fluoroquinolones, leaving the expanded-spectrum cephalosporins, ceftriaxone and cefixime,
as the only antibiotics currently recommended by the Centers for Disease Control (CDC).
Unfortunately, the emergence of strains over the past decade with decreased susceptibility to
these antibiotics (4), together with the recent isolation of gonococcal strains from Japan (5,
6) and France (7) with confirmed MICs for ceftriaxone of 2 μg/ml (>10-fold higher than
previous isolates), suggests that the continued effectiveness of these antibiotics is uncertain.
The marked decrease in susceptibility to the expanded-spectrum cephalosporins makes it
imperative that we understand the molecular mechanisms that lead to resistance and that
new antibiotics be developed.
Chromosomally mediated resistance to penicillin and expanded-spectrum cephalosporins is
complex and multi-faceted. Resistance arises following acquisition of multiple mutant
alleles of endogenous genes/loci that work together to increase resistance to the antibiotic
(8). N. gonorrhoeae is naturally competent, and thus resistance determinants can be
transferred from a resistant isolate to a susceptible strain in a step-wise manner by DNA
uptake and homologous recombination (9, 10). The first step is acquisition of an altered
penA allele encoding penicillin-binding protein 2 (PBP 2), the lethal target for penicillin in
the gonococcus. These altered forms, particularly in strains with decreased susceptibility to
cephalosporins, have evolved by interspecies recombination with closely related pathogenic
and commensal Neisseria species, including N. meningitidis, N. flavescens, N. cinerea, and
N. lactamica (11). A single altered penA allele can arise from multiple recombination events
and accumulate >60 mutations. A major goal is to understand how these changes affect β-
lactam binding and acylation of PBP 2.
All bacteria are surrounded by peptidoglycan, which confers rigidity and viability to the cell.
Peptidoglycan is composed of glycan strands of a repeating disaccharide, N-
acetylglucosamine-β-1,4-N-acetylmuramic acid, in which every muramic acid residue is
substituted with a peptide chain (12, 13). PBPs catalyze the cross-linking of the peptide
chains during the final steps of peptidoglycan synthesis. A serine nucleophile from the PBP
attacks the penultimate D-Ala residue of the D-Ala-D-Ala carboxy terminus of the peptide
chain, forming an acyl-enzyme bond that is subsequently attacked by an amino group from
another peptide chain, forming a cross-link between two glycan strands (transpeptidation).
β-lactam antibiotics, by virtue of their similarity to acyl-D-Ala-D-Ala, react with PBPs to
form stable acyl-enzyme complexes that effectively inhibit activity (14).
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PBPs are generally classified either as high-molecular-mass (HMM) PBPs, which catalyze
transpeptidation of peptide chains and are essential for cell viability, or low-molecular-mass
(LMM) PBPs, which catalyze carboxypeptidase or endopeptidase activity and are not
essential for cell viability (15). HMM PBPs are divided into two classes: Class A PBPs
catalyze both a penicillin-insensitive transglycosylase (TGase) activity and penicillin-
sensitive transpeptidase (TPase) activity, whereas Class B PBPs catalyze only TPase
activity. Further subdivision of each of these classes into A1 to A7 and B1 to B6 + B-like I
to B-like III has been proposed based on structural and homology considerations (16, 17).
All PBPs contain three conserved sequence motifs that form the catalytic center of the active
site: the SxxK tetrad, which contains the serine nucleophile that reacts with peptides and β-
lactams, the SXN triad, and the KTG triad. While these conserved motifs are mostly
invariant, substitutions nearby or in other regions surrounding the active site collaborate to
decrease the acylation rate with β-lactam antibiotics without compromising transpeptidase
activity (18-22).
PBP 2 variants from penicillin-resistant (but cephalosporin-susceptible) strains of N.
gonorrhoeae, a Class B PBP, commonly contain both an Asp insertion after Arg345 (termed
Asp345a) in the β2a-β2d hairpin loop adjacent to the active site and 4 to 8 mutations in the
C-terminus (23). We recently solved the crystal structure of PBP 2 from a penicillin-
susceptible strain of N. gonorrhoeae and a PBP 2 variant from a penicillin-resistance strain
containing 4 C-terminal amino acid substitutions (20). These structures shed light on the
mechanisms by which these C-terminal mutations decrease the rate of acylation of the PBP
2 by β-lactam antibiotics, but unfortunately no constructs harboring the Asp345a insertion
crystallized, and thus the structural mechanism by which this insertion lowers the rate of
acylation remains unclear.
In this study, we investigated the mechanism by which Asp345a insertions alter the
acylation rate of penicillin for PBP 2. We focused on the interaction of Asp346 (the amino
acid adjacent to Asp345a) with Ser363 (the X in the SXN motif), which is the most likely
interaction affected by Asp345a (20). We show that this interaction is essential for TPase
function (but not β-lactam-binding), and further, that all Class B PBPs have a conserved




FA19 is a penicillin- and cephalosporin-susceptible wild type strain that served as the
recipient strain for all of the transformation experiments (24). FA19 was grown on GC Broth
(GCB) agar plates containing supplements I and II (25) in a 4% CO2/96% air atmosphere at
37°C. In most cases, the wild-type penA gene from FA19 was used as the template for
mutations and 345a/346a insertions, but in some cases i.e., those where the mutations or
insertions did not decrease the k2/KS acylation rate constant more than threefold, the
penA35 gene from strain 35/02 (a cephalosporin intermediate-resistant or CephI strain; (26))
was used as template (see below). For transformation experiments, the penA genes being
transformed were either cloned into pUC18us, which is pUC18 containing a 10-bp
gonococcal uptake sequence (27), or were constructed by PCR and transformed directly into
FA19. In the latter case, one of the primers for PCR amplification contained the uptake
sequence appended to its 5′ end. The plasmid for overexpression and purification of PBP 2
constructs (a derivative of pMAL-C2; New England Biolabs, Beverly, MA) was described
in earlier publications (20, 28). E. coli strain MC1061 was used for routine subcloning,
while GW6011 (MC4100 lon-146::Tn10) was used for protein purification.
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Mutations and insertions were incorporated into the penA or penA35 gene by overlap-
extension PCR (29). The templates for the reactions were pUC18us-penA or pUC18us-
penA35 (21). For the 346a insertion library, the 3′ internal gene-specific primer was
complementary to the penA sequence from codons 340-346, contained three random bases,
and then had complementary sequence from codons 347-353, while the 5′ internal primer
consisted of codons 347-353. Following amplification of the two halves of the penA gene,
the individual amplification products were purified, mixed back together, and amplified with
only the outside vector-specific primers. The assembled large fragment was digested and
cloned back into pUC18us, the ligation was transformed into MC1061, and the library of
plasmid clones was purified. Sequencing of the library confirmed the presence of all four
bases in essentially equal amounts at the 3 positions of codon 346a.
Assessment of TPase activity of PBP 2 mutants by transformation
There is no in vitro assay capable of quantifying TPase activity of Class B PBPs, as these
PBPs do not react with model substrates or cross-link linear peptidoglycan. However, since
PBP 2 is essential for the growth and viability of N. gonorrhoeae (23, 30), we assessed
TPase function of the PBP 2 mutants by determining whether they were capable of
transforming N. gonorrhoeae. Previous experiments showed that resistant colonies could be
readily selected when FA19 was transformed with penA DNA encoding PBP 2 mutants with
≥ threefold decrease in the acylation rate constant and plated at penicillin concentrations just
above its minimal inhibitory concentration (MIC) (see below) (20). Anything below this
threshold was difficult to select without obtaining significant numbers of untransformed
colonies.
For those mutations that did not decrease the k2/KS of penicillin G below threefold, we
incorporated the mutations into PBP 235/02, which confers a 100-fold increase in the MIC
of cefixime when expressed in FA19 (31). While it is possible that the 345a/346a insertions
might affect activity of PBP 235/02 differently than wild-type PBP 2 (due to the presence of
58 amino acid changes), PBP 235/02-D345a was functional and capable of transforming
FA19, and thus there appear to be no negative interactions between the insertion and the
other alterations in PBP 235/02.
Transformation of penA mutant constructs into FA19 was accomplished as described
previously (32). Transformants were selected on GCB plates containing 0.02 μg/ml
penicillin G, which is 2-fold higher than its MIC (32). To verify correct recombination,
transformants were passaged on GCB plates, colonies were boiled in 25 μl water, spun
briefly to pellet cell debris, and the supernatants were used as templates in PCR reactions
with the appropriate penA primers. PCR products were sequenced by the UNC sequencing
facility or by Eton Bioscience Inc. (Research Triangle Park, NC). Transformations of
mutants in the penA35 allele from strain 35/02 were plated on GCB plates containing 0.01
μg/ml cefixime (~3-fold higher than its MIC) (21, 31).
Purification of PBP 2 variants
PBP 2 variants were purified as described previously (20). Briefly, the genes encoding each
variant were cloned into a derivative of pMAL-C2 (New England Biolabs, Beverly, MA),
pMAL-C2KV, which fuses His6-maltose-binding protein and an intervening tobacco etch
virus (TEV) protease site to amino acid 44 of PBP 2, and the proteins were expressed in E.
coli (this construct removes the N-terminal transmembrane anchor and greatly increases the
expression levels and solubility of the PBP). The fusion proteins were purified on a Ni2+-
NTA column (GE Healthcare, Piscataway, NJ), cleaved with His6-tagged TEV protease, and
the digests were re-chromatographed over a Ni2+-NTA column. The purified proteins were
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eluted in TNG buffer (20 mM Tris, 500 mM NaCl, 10% glycerol, pH 8.0) containing 15 mM
imidazole, while uncleaved protein, His6-TEV and His6-maltose-binding protein were
eluted with TNG buffer containing 250 mM imidazole. The proteins were dialyzed in TNG
buffer to remove imidazole, concentrated to ~ 6 mg/ml, and frozen at −80°C.
k2/KS measurements of the rate of acylation by β-lactam antibiotics
The reaction of β-lactam antibiotics with PBP 2 is denoted by the following equation:
, where E•S is the non-covalent enzyme-antibiotic
complex, E-S’ is the acyl-enzyme complex, and P the hydrolyzed antibiotic. k2/Ks constants,
which are a direct measure of the ability of an antibiotic to inhibit a PBP (33), were
calculated from first order rates of acylation of purified, soluble PBP 2 variants by
[14C]penicillin G (Moravek, Brea, CA), as previously described (20, 34). Graphs of PBP 2-
[14C]penicillin G complex formation versus time were obtained by incubating 27 μg of
protein with 0.5-1.0 μM [14C]penicillin G, and aliquots of ~4 μg were removed at 15 sec
intervals, precipitated with 5% trichloroacetic acid, filtered over Whatman GC-A filters, and
the filters were submitted to scintillation counting.
Bioinformatics
A Blast search using N. gonorrhoeae PBP 2 as a query was carried out using the Swiss
Institute for Bioinformatics Blast program (35) at www.expasy.org. The top 1000 sequences
were selected and those with >90% similarity were culled by the Blast program. Because
there were far fewer sequences with SDN and SCN motifs than SSN motifs in the original
search, the Blast search and culling was repeated using either PBP 2a from S. aureus (SDN
motif) or PBPA from M. tuberculosis (SCN motif) as the query sequence. The three groups
of sequences were then aligned separately using the multi-sequence alignment program,
MUSCLE (36). The region comprising the equivalent of the β2a-β2d hairpin extension loop
through the SXN motif of the different alignments was extracted and used to create
Sequence Logos (37) through the web based application, WebLogo (38)
(weblogo.berkeley.edu).
Proteolytic sensitivity of PBP 2 variants
Purified PBPs (100 μg) were diluted to 56 μl with TNG buffer, and 10 μl was removed and
added to 2.5 μl of 5X SDS-PAGE sample buffer (0 time point). Trypsin (1 μl of a 50 ng/μl
solution) was added to the remainder of the protein at room temperature, and 10 μl of the
digest was removed at 5, 10, 30, and 60 min and denatured as above. The samples were
heated at 95°C for 5 min after denaturation, and 10 μl of each sample was separated on a
10% SDS-polyacrylamide gel. The proteins were stained with Coommassie Brilliant Blue
R-250 and the gel was scanned on a Typhoon 9400 Variable Mode Imager (GE Healthcare,
Piscataway, NJ) using the red 633 nm laser for fluorescence excitation.
Results
Random 346a codon insertions
As shown by the crystal structure of PBP 2 (20), the Asp345a insertion is located after
Arg345 on the β2a-β2d loop that lies above the active site in close proximity to the SXN
active-site motif (Fig. 1A). The residue following the insertion site, Asp346, is involved in
an intimate hydrogen-bonding network in which the carboxylate of Asp346 contacts Ser363
(the X in the SXN motif) and two amide nitrogens at the N-terminal end of the α5 helix
(Fig. 1B), and we have hypothesized that the aspartate insertion exerts its effect by altering
this interaction (20). One of the curious aspects of the Asp345a insertion in PBP 2 is that
aspartate is the only amino acid observed in clinical isolates, and selection of transformants
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of a laboratory strain with a library of penA genes containing random codon insertions at
position 345a revealed only aspartate codon insertions, leading to the conclusion that
aspartate is the only amino acid insertion capable of decreasing susceptibility to penicillin
(39). However, because position 346 is also an aspartate, the assignment of the insertion
position is ambiguous, i.e. it could be Asp345a or Asp346a.
To investigate whether amino acid insertions (other than aspartate) at position 346a are
capable of decreasing susceptibility to penicillin, we constructed a library of penA genes
containing a randomized codon insertion at position 346a and used this to transform FA19 (a
penicillin-susceptible wild-type strain of N. gonorrhoeae), selecting for transformants with
decreased susceptibility to penicillin G. The penA genes from fifteen transformants were
amplified and sequenced, but in each instance, only an aspartate codon (either GAC or
GAT) at position 346a was recovered. These data indicate that an Asp-Asp couple at this
position in PBP 2 is requisite for decreasing penicillin susceptibility of N. gonorrhoeae.
Characterization of individual 345a and 346a insertion mutants of PBP 2
There are two potential explanations for the exclusive selection of an Asp-Asp couple: 1)
insertions of other amino acids do not decrease the rate of acylation, and thus would not be
selected by transformation of penicillin-susceptible recipient strains, or 2) insertion of amino
acids other than aspartate decreases acylation, but also disrupts the essential TPase activity
of PBP 2 and therefore cannot support growth. To distinguish between these two
possibilities, we used site-directed mutagenesis to insert a variety of amino acids at positions
345a and 346a, purified the mutant proteins, and determined their rates of acylation with
[14C]penicillin G. As shown in Table 1, nearly all of the insertions decreased the acylation
rate with [14C]penicillin G (the lone exception being His346a, which slightly increased the
acylation rate), with one insertion, Glu345a, having a greater effect on acylation than the
Asp345a insertion. However, none of these individual penA mutants except Asp345a or
Asp346a were capable of transforming FA19 to higher resistance, whereas transformants
with decreased susceptibility to penicillin G were readily obtained using a penA-P551S/
A516G double mutant, which has a k2/KS that is 2.9-fold lower than wild type (20). As
described in Materials and Methods, transformants of N. gonorrhoeae could be readily
selected using DNA encoding PBP 2 mutants with at least a threefold decrease in the k2/KS
constant of penicillin compared to wild-type, provided that the mutant was a functional
TPase.
Because the fold decreases in k2/KS values for PBP 2-H346a, -N345a and -Q345a mutants
were below the threefold threshold for selection of transformants on penicillin (Table 1), we
could not demonstrate unambiguously that these insertions were functional. Therefore, we
took advantage of a penA allele (penA35) from the penicillin-resistant, cephalosporin-
intermediate resistant strain 35/02, which confers a 100-fold increase in cefixime resistance
to FA19 (31). The penA35 allele contains 58 mutations compared to wild type penA, but
does not have the Asp345a insertion (26); therefore, if the insertion disrupts TPase activity,
no transformants containing the insertion should be recovered. The D345a, N345a, Q345a
and H346a insertions were introduced into penA35, and the resulting clones were used to
transform FA19 to increased cefixime resistance. Only the penA35-D345a construct resulted
in the growth of resistant colonies, strongly suggesting that the insertion of histidine,
asparagine, or glutamine at position 345a results in the loss of the essential TPase function.
Taken together, these data are consistent with the conclusion that only an Asp insertion at
position 345a or 346a is capable of both decreasing the rate of acylation of penicillin G and
retaining TPase activity.
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Role of Asp346 and Ser363 in TPase activity ofPBP 2
The interaction of Asp346 and Ser363 shown in Fig. 1B suggests that insertion of Asp345a
may impact enzyme activity by altering or disrupting the hydrogen bonds between Asp346
and Ser363, and therefore we employed a mutagenesis approach to investigate the roles of
these residues in the activity of PBP 2. Asp346 and Ser363 were mutated individually to
Ala, and each mutant PBP 2 variant was examined for its rate of acylation with penicillin G
and its ability to support growth of N. gonorrhoeae (as a measure of its TPase activity). The
acylation rates of PBP 2-D346A and PBP 2-S363A were both decreased around fivefold,
about the same as PBP2-D345a or PBP 2-6140CT (20), compared to wild-type PBP 2 (Table
1). Despite the fivefold decrease in the k2/KS of penicillin G, neither penA-D346A nor
penA-S363A was capable of transforming FA19 to decreased susceptibility (i.e. neither
supported growth of N. gonorrhoeae), whereas hundreds of transformants were obtained
with penA constructs encoding PBP 2-D345a or PBP2-6140CT. These data strongly suggest
that although the D346A and S363A mutations decrease the rate of acylation with penicillin
G, they also render the enzyme non-functional as a TPase, highlighting the importance of
the interaction between these two amino acids for catalyzing TPase activity.
Structural comparison of N. gonorrhoeae PBP 2 with other Class B PBPs
Another well-studied Class B PBP whose structure is known, PBP 2x from S. pneumoniae
(SpPBP 2x), also contains an SSN active-site motif (40). While these two PBPs share only
20% sequence identity, inspection of the crystal structure of SpPBP 2x revealed that Ser396
(the middle serine in the SSN motif) and Asp373 in the equivalent of the β2a-β2d loop in
PBP 2x form a nearly identical set of interactions as Asp346 and Ser363 in NgPBP 2 (Fig.
2A,B). Indeed, superimposition of the two structures shows that there is almost complete
overlap of the two residues (Fig. 1 Supplemental), suggesting a broad conservation of
structure and function of this interaction, at least in PBPs harboring an SSN motif.
We recently reported the structure of the Class B-like PBP, PBPA from M. tuberculosis
(MtPBPA) (41), which shows an unusual disulfide bond between a Cys residue in the X
position of the SXN motif and a Cys residue in the equivalent of the β2a-β2d loop (Fig. 2C).
The architecture of this covalent bond is very reminiscent of the Asp-Ser interaction in
NgPBP 2 and SpPBP 2x. An additional Class B PBP whose structure is known, PBP 2a
from methicillin-resistant Staphylococcus aureus (SaPBP 2a) (42), contains an SDN motif in
which the Asp carboxylate forms an electrostatic interaction with an Arg residue in the loop
equivalent to the β2a-β2d loop in NgPBP 2 (Fig. 2d). Thus, in four different Class B PBPs,
an interaction between the middle residue of the SXN motif and a residue within the
equivalent of the β2a-β2d loop is observed. These data prompted a bioinformatics analysis
to determine the extent of this apparently conserved interaction in Class B PBPs from a wide
range of bacterial genera and species.
Multiple sequence alignment of Class B PBPs
We identified the top 1000 sequences in a Blast search using NgPBP 2 as a query (see
Methods for more details) and culled highly similar (>90%) sequences to decrease
redundancy. Following multi-sequence alignment, three major groups (which we denote as
Groups 1-3) of Class B PBPs were evident: Group 1 PBPs contained an SSN motif, Group 2
PBPs contained an SCN motif, and Group 3 PBPs contained an SDN motif. To identify as
many group members as possible, BLAST searches for Group 2 and Group 3 PBPs were
undertaken using MtPBPA and SaPBP 2a, respectively, as query sequences, and again
redundant sequences from each of the three groups were culled by eliminating those with
>90% sequence identity. The sequences in each group were then aligned using the multi-
alignment program MUSCLE (36). Below, we summarize the major findings of these
analyses.
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SSN-containing PBPs (Group 1)—This is the largest group, with 364 PBPs included in
the alignment (Supplemental Fig. 2). Strikingly, in 95% of the sequences, a conserved Asp
residue is observed between 16 and 24 residues N-terminal to the SSN motif (Fig. 3). The
remaining 5% contain either an asparagine or serine residue at this position of the alignment,
both of which are hydrogen-bonding acceptors/donors that presumably could substitute for
the aspartate in linking the β2a-β2d loop to the SSN motif. We also observed that nearly
10% of the PBPs (30/364) had alternative residues, e.g. aspartate, glutamine, and cysteine, at
the third position of the SSN motif.
SCN-containing PBPs(Group 2)—This group comprised 135 sequences (Supplemental
Fig. 3), which could be further divided into two subgroups (2a and 2b). Subgroup 2a
sequences (110 members) contained a conserved cysteine 11-16 residues N-terminal to the
SCN motif (Fig. 3 and Supplemental Fig. 3A), while in Subgroup 2b sequences (25
members), the conserved cysteine was located farther N-terminal to the motif (24-42
residues) (Fig. 3 and Supplemental Fig. 3B). None of the Subgroup 2a PBPs and only 20%
of the Subgroup 2b PBPs harbored an additional cysteine residue in the region between the
SXXK and SCN motifs, but, if present, none were conserved.
SDN-containing PBPs (Group 3)—Group 3 PBPs were the smallest group, with only
45 representatives (Fig. 3 and Supplemental Fig. 4). Thirty-four of these sequences (75%)
contained a conserved arginine in the same relative position as in SaPBP 2a, while the
remaining 11 (25%) contained a threonine residue at that position, which, as posited above,
could substitute in the interaction of the loop with Asp463 in the SDN motif (this interaction
would be the reverse of that in NgPBP 2 and SpPBP 2x). Taken together, it appears that an
interaction between the X residue of the SXN motif and a residue within the equivalent of
the β2a-β2d loop is highly conserved in Class B PBPs.
Analysis of NgPBP 2 with cysteine and aspartate substitutions at Ser363: To determine
if either a cysteine or aspartate residue could substitute for Ser363 in the SXN motif of
NgPBP 2, we incorporated these mutations into the protein and determined the k2/KS
constants for [14C]penicillin G (Table 1). Whereas the S363D mutation lowered the
acylation rate of NgPBP 2 by 7-fold, the S363C mutation had only a minor effect on
acylation (1.5-fold decrease). Transformation experiments to assess function revealed that
neither of mutant genes was capable of transforming FA19 to higher resistance, whereas in
the same experiment the penA-D345a gene generated hundreds of transformants. Because
substitution of Ser363 with Asp would likely disrupt interaction with Asp346 from the β2a-
β2d loop, we also mutated Asp346 in penA-S363D to Arg to mimic the interaction in
SaPBP 2a, but while the acylation rate remained low, no transformants with reduced
susceptibility could be obtained.
While these results strongly suggested that the S363D mutation abolishes the TPase activity
of NgPBP 2, the inability to select transformants containing the S363C mutation could have
been due to its minimal effects on acylation. Therefore, as described above, we incorporated
the S363C mutation into the highly resistant penA35 allele and transformed the penA35-
S363C mutant into FA19. Transformants were selected for increased resistance to cefixime,
and sequencing of the penA gene from these colonies confirmed the presence of the S363C
mutation. Thus, cysteine is capable of substituting for Ser363 without compromising the
TPase activity of NgPBP 2, presumably by preserving the interaction between the β2a-β2d
loop and the SXN motif.
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Flexibility of the β2a-β2d loop in PBP2-Asp345a insertion mutant
In SpPBP 2x from the cefotaxime-resistant strains 5204 and 328 (PBP 2x sequences from
these strains are nearly identical), two mutations involved in decreasing the rate of acylation
of cefotaxime, I371T and R384G, are located in the equivalent of the β2a-β2d loop of
NgPBP 2. Interestingly, the structure of SpPBP 2x from strain 328 revealed disordering and
displacement of approximately 30 residues encompassing the equivalent of the β2a-β2d loop
up to the SSN motif of the active site (43), and increased susceptibility of this loop to
proteolytic digestion of purified PBP 2x from strain 5204 provided corroborating evidence
of this flexibility in solution (44). The flexibility of this loop has been posited to underlie the
effects of the substitutions on the acylation rate and decreased MICs.
To examine whether the Asp345a insertion in NgPBP 2 increases flexibility of the β2a-β2d
loop in a manner similar to the aforementioned mutations in SpPBP 2x, we carried out
proteolytic susceptibility experiments for PBP 2 and PBP 2-Asp345a. As shown in Fig. 4A
and 4B, these two proteins had identical sensitivities to trypsin in solution. The lack of
trypsin sensitivity of PBP 2-D345a is not due to an absence of cleavage sites, as the β2a-β2d
loop contains three potential trypsin sites, following Arg331, Lys338, and Arg345. We also
examined whether mutation of either D346 or S363 to alanine, both of which abolish TPase
activity (as indicated by failure to transform N. gonorrhoeae), disrupts the tethering of the
β2a-β2d loop to the SSN motif, thereby inducing flexibility and increasing proteolytic
sensitivity of the mutant enzymes. As shown in Fig. 4C and 4D, both mutations markedly
increased proteolytic sensitivity of PBP 2 compared to the wild-type or Asp345a insertion
mutant. These data show that loss of TPase function is likely due to an increased flexibility
of the β2a-β2d loop and suggests that the Asp345a insertion acts by a specific mechanism to
lower the rate of acylation and not by increasing flexibility of the β2a-β2d loop.
Discussion
Asp345a insertions are nearly ubiquitous in penicillin-resistant strains of N. gonorrhoeae,
but the mechanism by which the Asp345a insertion lowers the acylation rate for penicillin
while preserving TPase function is unknown. In the absence of structural information, we
employed mutagenesis to address this question and identified an interaction between the
middle residue of the SXN motif (Ser363 in NgPBP 2) and a residue in a loop that precedes
the motif (Asp346 in NgPBP 2) that is both required for TPase activity and important (but
not essential) for penicillin binding. Mutation of either of these residues mediating this
interaction to Ala lowers the k2/KS acylation rate constant by about the same fold as an
Asp345a insertion, but also renders PBP 2 inactive as a TPase (based on its inability to
support growth). Bioinformatics analyses revealed that an interaction between the SXN
motif and the loop above the active site is a highly conserved feature of all Class B PBPs.
The implications of these findings for the transpeptidase function of PBPs, as well as
resistance to β-lactams, are discussed below.
Because there is no in vitro assay to quantify TPase activity, we assessed the capacity of
PBP 2 mutants to transform N. gonorrhoeae to decreased penicillin susceptibility as a
measure of TPase function. As long as the mutation decreased the k2/KS of penicillin G ≥
threefold (a threshold at which resistant colonies could be readily obtained), transformation
of FA19 to increased penicillin resistance was a straightforward and reliable method,
because PBP 2 is essential and loss of TPase activity would not support bacterial growth.
While this method is qualitative, it is clinically relevant, as those mutations that lower the
TPase activity below the level that supports growth would never be observed in clinical
isolates. Hence, the transformation assay is a useful and informative method to determine
the affects of mutations on TPase activity of essential PBPs, especially in naturally
competent organisms such as N. gonorrhoeae.
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The observation that only an aspartate insertion at position 345a or 346a decreases the rate
of penicillin binding of PBP 2 without compromising TPase activity, whereas insertions of
other amino acids, including those that are similar to aspartate (e.g. glutamate or
asparagine), disrupt TPase activity, is intriguing. These data indicate that only an Asp-Asp
couple can lower k2/KS whilst also preserving TPase function. We also show that both PBP
2-D346A and PBP 2-S363A (neither of which catalyze TPase activity) are more susceptible
to proteolysis compared to wild-type, suggesting that once the tether between the β-hairpin
loop and the SXN motif is disrupted, the loop becomes more flexible. In contrast, the D345a
insertion does not increase sensitivity to proteolysis, suggesting that the loop remains
tethered. Hence, the Asp insertion lowers reactivity with penicillin in a very specific way,
most likely through perturbation of the interaction of Asp346 in the β2a-β2d loop with
Ser363 of the SSN motif. One possibility to explain the apparent requirement of an Asp-Asp
couple is that one of the two aspartates is needed to retain the required interaction of the
loop with Ser363, while the other aspartate alters that interaction in a subtle way that
decreases the rate of acylation of penicillin G.
One of the most surprising outcomes of this study was the essentially absolute conservation
of an interaction of a residue in the loop with the middle residue of the SXN motif in Class
B PBPs that was independent of the physical nature of the interaction. When bioinformatics
and structural data are considered together with our mutational and biochemical analyses of
NgPBP 2, it is clear that all Class B PBPs have a crucial and highly conserved connection
between the β-hairpin loop above the active site and the X residue in the SXN motif (Fig 3),
suggesting that this connection is necessary for TPase activity of the PBP.
Inspection of the crystal structures of three bifunctional Class A PBPs, PBPs 1a and 1b from
S. pneumoniae and PBP 2 from S. aureus, suggests that a similar connection also exists in
other HMM PBPs. SpPBP 1a contains an SRN motif, and the arginine (Arg429) of the motif
interacts with Asp412, which is located on the equivalent of the β2a-β2d hairpin extension
loop that precedes the SRN motif (Fig. 5A) (45). SpPBP 1b harbors a tryptophan (W517) in
the middle position of the SXN motif, and this aromatic amino acid forms two interactions
with residues in the loop: 1) a π-π interaction with the phenolic side chain of Tyr498, and 2)
a carboxamide-π interaction with Asn485 (Fig. 5B) (46, 47). Lastly, SaPBP 2 has an SFN
motif where Phe455 forms a π-π interaction with the loop residue His442, which is held in
place by interactions of the imidazolium nitrogens with two neighboring aspartate residues
(Fig. 5C) (48). Although a comprehensive analysis has not been carried out, it appears that
Class A PBPs also contain a conserved interaction between the loop that resides above the
active site and the middle residue of the SXN motif.
The results from this study are highly reminiscent of those with E. coli PBP 5, a LMM PBP/
D-Ala carboxypeptidase (CPase) with a relatively high β-lactamase activity (t1/2 of the
penicilloyl-enzyme complex ≈ 10 min) (49). This PBP contains a loop (referred to as the
74-90 loop) that precedes the SXN motif (S110GN112 in EcPBP 5) in a similar position in
the primary sequence as the β2a-β2d hairpin extension loop in NgPBP 2. Two consecutive
Ser residues on this loop (Ser86 and Ser87) interact with side chain and main chain atoms of
residues within or adjacent to the SGN motif (Fig. 5D) (50). Although these interactions are
fundamentally different than those discussed above for Class B PBPs, there is still a strong
similarity in that the 74-90 loop of PBP 5 connects to the SGN motif through hydrogen-
bonding interactions.
We have studied a PBP 5 point mutant (PBP 5-G105D; also called PBP 5), which has a 5-
fold decrease in acylation rate (relative to wild-type) with penicillin G, but is deficient in
CPase activity (49, 51). The crystal structure of PBP 5 revealed that while all of the active
site motifs were intact, the 74-90 loop was disordered, suggesting that an ordered loop is
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essential for carboxypeptidase activity but not β-lactam binding (52). Subsequent
biochemical and mutational experiments, in which the 74-90 loop was deleted in the wild-
type background or the two Ser residues were mutated to Ala, showed that disordering of the
loop was the primary reason for the loss of CPase activity and reduced penicillin binding in
the mutant enzyme (50). Given the equivalence of the 74-90 loop to the β2a-β2d loop in
NgPBP 2, these results are strikingly similar to our observations in the PBP 2-D346A and -
S363A mutants (i.e. a decrease but not loss of penicillin-binding and loss of functional
TPase/CPase activity).
These results all point to a critical role of the β2a-β2d loop (and its equivalents) in TPase/
CPase activity of PBPs. One explanation for the importance of this interaction in TPase
activity is that the loop may be critical for binding and orienting the natural peptide
substrate; this view is supported by the crystal structure of E. coli PBP 6 in complex with a
peptidoglycan fragment containing a pentapeptide in which there are hydrogen bonds
between the equivalent loop and the L-Lys of the peptide (53). Alteration of the structure of
the loop by insertions other than aspartate would likely prevent such interactions and
therefore compromise TPase activity. By comparison, β-lactam antibiotics are much smaller
and interactions with the β2a-β2d loop are less important for penicillin-binding activity;
consequently, acylation by β-lactams is less affected by the Asp345a insertion.
Our study suggests that mutations or insertions into the loop preceding the SXN motif can
be exploited for increasing resistance, provided that the PBPs remain functional TPases.
Indeed, two other PBPs, SpPBP 2x and PBP5fm from penicillin-resistant strains of S.
pneumoniae and Enterococcus faecium respectively, have acquired mutations or an insertion
in the loop that have been shown to confer decreased susceptibility to β-lactam antibiotics.
PBP5fm, a Group 3 PBP with an SDN motif and conserved arginine in the loop, harbors an
insertion of a serine (Ser466′) that, when present, increases the MIC of penicillin twofold
(54, 55). In SpPBP 2x from strain 5204, reversion of two mutations in the loop, I371T and
R384G, back to wild-type either individually or together and subsequent recombination back
into S. pneumoniae resulted in a two- to threefold decrease in the MIC of cefotaxime (44).
As mentioned above, I371T and R384G in S. pneumoniae strains 328 and 5204 increase
flexibility of the equivalent of the β2a-β2d loop, as evidenced by increased proteolytic
degradation of the enzyme and disordering of the loop in the crystal structure (43, 44). Our
data with NgPBP 2, however, point to an entirely different and more specific mechanism
because the Asp345a insertion does not increase the proteolytic susceptibility of the protein.
Indeed, the increased proteolytic sensitivity of the non-functional PBP 2-D346A and -
S363A mutants suggests that disruption of the loop-SXN motif interaction induces disorder
in this loop and is responsible for loss of essential TPase activity.
In conclusion, insertion of an aspartate, but no other amino acid, in the β2a-β2d loop of
NgPBP 2 at position 345a or 346a lowers the rate of acylation by penicillin G, whilst
preserving essential TPase function. This, together with the requirement of an Asp-Asp
couple and the absence of flexibility in the β2a-β2d resulting from the insertion, suggests a
very precise mechanism underlying this mechanism of penicillin resistance involving
perturbation but not disruption of an important interaction between the β2a-β2d loop and the
SxN active site motif. The importance of this interaction is highlighted by its conservation in
Class B and other PBPs. Overall, these findings hint at the delicate balancing act that occurs
during the evolution of resistance, in which mutations lower the susceptibility of the target
for one ligand (the antibiotic) without compromising the natural function of the enzyme with
its peptide substrate.
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Fig. 1. Interaction of Asp346 in the β-hairpin extension of NgPBP 2 with the middle Ser in the
SSN active-site motif
A, the structure of NgPBP 2, with the β-hairpin extension (also referred to as the β2a-β2d
loop) shown in green. The side chains of the residues within the three active site motifs are
shown as orange bonds, and the backbone of the SxN motif is colored red. The active site,
N- and C-termini, and the penicillin-binding/TPase and N-terminal domains are highlighted.
B, a closer view of the active site, showing hydrogen-bonding interactions between residues
in the interaction of Asp346 in the β2a-β2d loop with Ser363 of the SSN motif. Putative
hydrogen bonds are shown as dashed lines and structural elements are labeled.
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Fig. 2. Conservation of the interaction between the X residue of the SXN motif with a residue in
the preceding loop in several Class B PBPs
A, PBP 2 from N. gonorrhoeae (PDB code 3EQU; (20)), showing the interaction between
Asp346 and Ser363. Structural elements and the SXN motif are as shown; B, PBP 2x from
S. pneumoniae (1QME; (40)), showing the interaction between Asp373 and Ser396; C, M.
tuberculosis PBPA(3LO7; (41)), showing a disulfide bond between Cys266 and Cys282;
and D, PBP 2a from methicillin-resistant S. aureus (1VQQ; (42)), showing the interaction
between Arg445 and Asp463. Hydrogen bonds are depicted by the dotted lines, and the
numbers next to the lines refer to the lengths of the bonds in Å. The orientation of the PBPs
in A-D is the same as in Fig. 1B.
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Fig. 3. Conservation of an amino acid in the β2a-β2d loop that interacts with the X residue in the
SXN motif in each of the three groups of PBPs
The conservation of a residue in the loop preceding the SXN motif and the X residue of that
motif in each PBP Group as shown by a WebLogo plot (37, 38) of multiple-sequence
alignments. The connected arrows in each plot point to the two interacting residues in each
group of PBPs. See text for details.
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Fig. 4. Trypsin sensitivity of wild-type and mutant PBP 2 variants
PBP 2 variants (83 μg) were incubated with 50 ng trypsin in 20 mM Tris, pH 8.0, 500 mM
NaCl, and 10% glycerol at room temperature. At the indicated times, samples were
withdrawn, added to SDS-PAGE loading buffer, and separated on a 10% gel. The gels were
stained with Coomassie Brilliant Blue R-250. The molecular weights of protein standards
are indicated on the side of the first gel.
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Fig. 5. The interaction between amino acids in the SXN motif and within the β-hairpin loop is
conserved in other non-Class B PBPs
A, PBP 1a from S. pneumoniae (PDB code 2C6W; (45)), a bifunctional Class A PBP; B,
PBP 1b from S. pneumoniae (2FFF; (46, 47)), a Class A PBP; C, PBP 2 from S. aureus
(2OLU; (48)), a Class A PBP; and D, PBP 5, a LMM CPase from E. coli (1NZO; (50)).
Hydrogen bonds are shown as dashed lines. The orientation of the PBPs in A-D is the same
as in Fig. 1B and 2.
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Table 1
Kinetic constants of PBP 2 mutants
The k2/Ks constants of [14C]penicillin G for the indicated PBP 2 variants were determined using purified
protein as described in Materials and Methods. Insertions are denoted by a small a following the amino acid,
whereas mutations are denoted in capitals (e.g. PBP 2-D346a is an insertion after amino acid 346, while PBP
2-D346A is a mutation of D346 to alanine.




PBP 2 WT 74,700 ±5,000 (n=8) --- +
PBP 2-D345aorD346a 12,200 ± 2,400 (n=16) 6.1 +
PBP 2-P551S/A516G 25,900 ±2,400 (n=8) 2.9 +
PBP 2-E345a 19,900 ± 900 (n=4) 3.8 —
PBP 2-N345a 31,200 ± 1,800 (n=4) 2.4 -
PBP 2-Q345a 45,400 ± 1,400 (n=4) 1.6 -
PBP 2-A345 a 19,100 ± 900 (n=4) 3.9 -
PBP 2-E346a 5,100 ± 400 (n=4) 14.6 -
PBP 2-N346a 11,800 ± 100 (n=5) 6.3 -
PBP 2-Q346a 20,700 ±1,400 (n=4) 3.6 -
PBP 2-K346a 16,300 ± 1,200 (n=4) 4.6 -
PBP 2-H346a 114,500 ± 6,300 (n=5) 0.7 -
PBP 2-D346A 14,600 ± 800 (n=8) 5.1 -
PBP 2-S363A 16,400 ±3,800 (n=8) 4.6 -
PBP 2-S363C 51,300 ±2,100 (n=8) 1.5 +
PBP 2-S363D 10,400 ±2,300 (n=8) 7.2 -
a
Fold change in k2/Ks relative to PBP 2 WT.
b
TPase activity is defined as the capacity of the PBP 2 variant to support cell growth (see Methods for details).
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